1
2
3
4
Prick, B.W. (Babette), Steegers, E.A.P. (Eric), Jansen, A.G. (Gerard), Hop, W.C.J. (Wim), Essink-Bot, M.L.E. (Marie-Louise), Peters, N.C.J. (Nina), Uyl-de Groot, C.A. (Carin), Papatsonis, D.N.M. (Dimitri), Akerboom, B.M.C. (Bettina), Metz, G.C.H. (Godfried), Bremer, H.A. (Henk), Loon, A.J. (Aren) van, Stigter, R.H. (Rob), Post, J.A.M. (Joris) van der, Alphen, M. (Marcel) van, Porath, M. (Martina), Rijnders, R.J.P. (Robbert), Spaanderman, M.E.A., Schippers, D.H. (Daniela), Bloemenkamp, K.W.M. (Kitty), Boers, K.E. (Kim), Scheepers, H.C.J., Roumen, F.J.M.E. (Frans), Kwee, A. (Anneke), Schuitemaker, N.W.E. (Nico), Mol, B.W.J. (Ben), Rhenen, D.J. (Dirk Jan) van, Duvekot, J.J. (Hans)
2010
2010
5
6
7
8
Alfian, Sofa Dewi, Worawutputtapong, Pawida, Schuiling-Veninga, Catharina C.M., Van Der Schans, Jurjen, Bos, JH, Hak, Eelko, Denig, Petra
Veröffentlicht in: Alfian , S D , Worawutputtapong , P , Schuiling-Veninga , C C M , Van Der Schans , J , Bos , JH , Hak , E & Denig , P 2017 , ' Predictors of non-adherence to and non-persistence with statin therapy among patients on oral diabetes medication in the netherlands: A retrospective inception cohort study ' , Pharmacoepidemiology and Drug Safety , vol. 26 , no. Supplement 2 , 856 , pp. 517-518 . https://doi.org/10.1002/pds.4275;
2017
Veröffentlicht in: Alfian , S D , Worawutputtapong , P , Schuiling-Veninga , C C M , Van Der Schans , J , Bos , JH , Hak , E & Denig , P 2017 , ' Predictors of non-adherence to and non-persistence with statin therapy among patients on oral diabetes medication in the netherlands: A retrospective inception cohort study ' , Pharmacoepidemiology and Drug Safety , vol. 26 , no. Supplement 2 , 856 , pp. 517-518 . https://doi.org/10.1002/pds.4275;
2017
9
10
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018